NASDAQ:MSON Misonix (MSON) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$26.54▼$26.5450-Day Range$24.89▼$26.5452-Week Range$11.04▼$26.99Volume2 shsAverage Volume60,302 shsMarket Capitalization$462.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Misonix (NASDAQ:MSON) StockMisonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.Read More Receive MSON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter. Email Address MSON Stock News HeadlinesJune 2, 2023 | msn.com'Important' medieval palace 'saved for the future' by masonsJune 2, 2023 | news.yahoo.comMason's 'The Courthouse Pub' couldn't pick one dish for signature dish weekJune 4, 2023 | Altimetry (Ad)Surprising "Twist" Hands Biden Landslide Re-election?This could make it harder than ever to hang onto the money you make as Progressives gain power, and America slides further towards Socialism.June 2, 2023 | bizjournals.comCrazy Mason Milkshake Bar coming to PittsburghJune 2, 2023 | msn.comMasons gave up their weekend to help keep runners safeJune 1, 2023 | msn.comCharities in Cornwall awarded over £100k by FreemasonsMay 30, 2023 | msn.com90 Day Fiancé: Love In Paradise - Jordan Mason's Felony Arrest ExplainedMay 30, 2023 | msn.comBoxing clever - Freemasons have raised over £250,000 in totalJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 27, 2023 | msn.com90 Day Fiancé: What We Know About Jordan Mason's Secret MarriageMay 27, 2023 | msn.comWas 'God's Cop' Sir James Anderton a Freemason? Auction of late GMP boss' belongings raises questionsMay 26, 2023 | es-us.finanzas.yahoo.comInventHelp Inventor Develops Ultimate Cement Leveler for Stone Masons (TRO-893)May 26, 2023 | wsj.comMysteries: Tim Mason’s ‘The Nightingale Affair’May 25, 2023 | msn.comBroad Street’s iconic 150-year-old Masonic Temple is not ‘a secret, forbidden place’May 25, 2023 | msn.comAlameda County launches investigation into Sophia Mason's deathMay 24, 2023 | msn.comOne of the largest firms in Belfast, Pinsent Masons makes six senior promotionsMay 20, 2023 | news.yahoo.comPalestine Masons to host second annual golf tournamentMay 17, 2023 | msn.comAre All Your Fashion Bros Secretly Obsessed With Buck Mason's T-Shirts?May 16, 2023 | msn.comFrank Mason’s KU trophies are up for auction. He wants them back, but it’s complicatedMay 13, 2023 | msn.comPerry Mason's Paul Raci Didn't Know Lydell Was Going To Be Such A Horrid Character [EXCLUSIVE]May 13, 2023 | msn.comCornish freemason celebrates partner's initiation in first for Cornwall and EnglandMay 13, 2023 | msn.comEven Perry Mason's Producers Never Know Where The Twists And Turns Will LeadMay 10, 2023 | news.yahoo.comMason's Western & Southern Open could move to Charlotte; local lawmaker seeks funds aimed at keeping it hereMay 10, 2023 | msn.comRyan Mason’s ‘clear message’ for Tottenham Hotspur ahead of Aston Villa battleMay 9, 2023 | technews.tmcnet.comK&N Engineering Joins Infrastructure Masons to Advance Sustainable Digital InfrastructureMay 8, 2023 | startribune.comReview: The Kanneh-Mason siblings perform for the Schubert Club's 140th anniversaryMay 2, 2023 | msn.comTottenham: Ryan Mason’s biggest issue shows Spurs’ chronic lack of investment in a key areaSee More Headlines MSON Company Calendar Last Earnings9/02/2021Today6/04/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Laboratory Apparatus & Furniture Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:MSON CUSIPN/A CIK880432 Webwww.misonix.com Phone(631) 694-9555Fax631-694-9412Employees254Year Founded1959Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,470,000.00 Net Margins-19.55% Pretax Margin-19.37% Return on Equity-10.36% Return on Assets-7.29% Debt Debt-to-Equity Ratio0.29 Current Ratio2.61 Quick Ratio1.92 Sales & Book Value Annual Sales$74.02 million Price / Sales6.24 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book3.42Miscellaneous Outstanding Shares17,410,000Free Float11,893,000Market Cap$462.06 million OptionableNot Optionable Beta1.36 Social Links Key ExecutivesStavros G. VizirgianakisChief Executive Officer & DirectorAllan R. StaleyPresidentSharon W. KlugewiczChief Operating OfficerJoseph P. DwyerChief Financial Officer, Secretary & TreasurerDaniel VoicVP-Engineering, Research & DevelopmentKey CompetitorsDomoNASDAQ:DOMOStoneridgeNYSE:SRISimilarwebNYSE:SMWBVishay Precision GroupNYSE:VPGMitek SystemsNASDAQ:MITKView All Competitors MSON Stock - Frequently Asked Questions How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.02. The medical equipment provider had revenue of $19.69 million for the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%. What is Michael A. McManus Jr.'s approval rating as Misonix's CEO? 3 employees have rated Misonix Chief Executive Officer Michael A. McManus Jr. on Glassdoor.com. Michael A. McManus Jr. has an approval rating of 33% among the company's employees. This puts Michael A. McManus Jr. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Misonix own? Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Varian Medical Systems (VAR), Sociedad Química y Minera de Chile (SQM), Avadel Pharmaceuticals (AVDL), Second Sight Medical Products (EYES), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Ardelyx (ARDX) and Athenex (ATNX). What is Misonix's stock symbol? Misonix trades on the NASDAQ under the ticker symbol "MSON." What is Misonix's stock price today? One share of MSON stock can currently be purchased for approximately $26.54. How much money does Misonix make? Misonix (NASDAQ:MSON) has a market capitalization of $462.06 million and generates $74.02 million in revenue each year. How many employees does Misonix have? The company employs 254 workers across the globe. How can I contact Misonix? Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The official website for the company is www.misonix.com. The medical equipment provider can be reached via phone at (631) 694-9555 or via fax at 631-694-9412. This page (NASDAQ:MSON) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Misonix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.